β-lactam MICs correlate poorly with mutant prevention concentrations for clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa

被引:20
作者
Gugel, J [1 ]
Pereira, ADS [1 ]
Pignatari, ACC [1 ]
Gales, AC [1 ]
机构
[1] Univ Fed Sao Paulo, Div Infect Dis, Lab Alerta, Sao Paulo, Brazil
关键词
D O I
10.1128/AAC.00144-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:2276 / 2277
页数:2
相关论文
共 9 条
[1]  
[Anonymous], [No title captured]
[2]  
*COM ANT SOC FRANC, 2006, COMM 2006
[3]   Antimicrobial resistance among Streptococcus pneumoniae in the United States:: Have we begun to turn the corner on resistance to certain antimicrobial classes? [J].
Doern, GV ;
Richter, SS ;
Miller, A ;
Miller, N ;
Rice, C ;
Heilmann, K ;
Beekmann, S .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) :139-148
[4]   Low correlation between MIC and mutant prevention concentration [J].
Drlica, K ;
Zhao, XL ;
Blondeau, JM ;
Hesje, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :403-404
[5]   Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America [J].
Gales, AC ;
Gordon, KA ;
Wilke, WW ;
Pfaller, MA ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (01) :61-64
[6]   Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin [J].
Li, XY ;
Zhao, XL ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :522-524
[7]   Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli [J].
Marcusson, LL ;
Olofsson, SK ;
Lindgren, PK ;
Cars, O ;
Hughes, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :938-943
[8]   DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance [J].
Zhao, XL ;
Xu, C ;
Domagala, J ;
Drlica, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13991-13996
[9]   Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies [J].
Zhao, XL ;
Drlica, K .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S147-S156